JPH01230659A - Tacky pva hydrogel composition - Google Patents

Tacky pva hydrogel composition

Info

Publication number
JPH01230659A
JPH01230659A JP5796088A JP5796088A JPH01230659A JP H01230659 A JPH01230659 A JP H01230659A JP 5796088 A JP5796088 A JP 5796088A JP 5796088 A JP5796088 A JP 5796088A JP H01230659 A JPH01230659 A JP H01230659A
Authority
JP
Japan
Prior art keywords
pva
chloride
gel
adhesive
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5796088A
Other languages
Japanese (ja)
Other versions
JP2824460B2 (en
Inventor
Jiyoukiyuu Gen
丞烋 玄
Yoshito Ikada
義人 筏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO MATERIAL YUNIBAASU KK
Original Assignee
BIO MATERIAL YUNIBAASU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO MATERIAL YUNIBAASU KK filed Critical BIO MATERIAL YUNIBAASU KK
Priority to JP63057960A priority Critical patent/JP2824460B2/en
Publication of JPH01230659A publication Critical patent/JPH01230659A/en
Application granted granted Critical
Publication of JP2824460B2 publication Critical patent/JP2824460B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Colloid Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PURPOSE:To obtain the title composition excellent in water retentivity low- temperature flexibility and ionic conductivity and useful for, e.g., a percutaneously absorbable preparation or a gel for a bioelectrode, by dissolving a bivalent metal salt and PVA in water by heating under specified conditions and cooling the solution. CONSTITUTION:A metal chloride which is a bivalent metal salt which does not form any complex with a molecular chain of PVA by a coordination bond and is selected from among CaCl2, ZnCl2, SrCl2, PdCl2, BaCl2, BiCl2, BeCl2, MgCl2, MnCl2 and NiCl2 in such an amount that the content in the desired hydrogel is 2-90wt.% is dissolved in water, and PVA of a viscosity-average degree of polymerization >=500 and a degree of saponification >=80mol% is added to the solution in an amount to give a PVA content of 5-80wt.% in the hydrogel, dissolved by heating, cast on, for example, a glass plate and allowed to gel by cooling.

Description

【発明の詳細な説明】 [工業上の利用分野] 本発明は、生体研究用、生体治療用、あるいは生体診断
用等の生体電極用のイオン導電性粘着剤、および経皮吸
収製剤用、冷却治療用等の含水貼付剤の基剤として用い
られる粘着性に優れたハイドロゲル組成物に関する。
Detailed Description of the Invention [Industrial Field of Application] The present invention relates to an ion conductive adhesive for biological electrodes for biological research, biological treatment, or biological diagnosis, and for transdermal absorption preparations and cooling adhesives. The present invention relates to a hydrogel composition with excellent adhesive properties that can be used as a base for water-containing patches for therapeutic purposes.

[従来の技術] ハイドロゲルとは、水には溶けず水を多及に包含してい
るゲルのことである。そうしたハイドロゲルは古くから
知られているが、近年1機能性材料に対する関心が高ま
るとともに、その性質が注目されるようになってきてい
る。たとえば、ソフトコンタクトレンズや医薬の徐放性
担体のような医用材料として、または酵素や菌体の固定
化担体、保冷用熱媒体、芳香剤の徐放性担体などとして
用いられている。
[Prior Art] A hydrogel is a gel that does not dissolve in water but contains a large amount of water. Although such hydrogels have been known for a long time, interest in monofunctional materials has increased in recent years, and their properties have been attracting attention. For example, they are used as medical materials such as soft contact lenses and sustained-release carriers for medicines, as immobilized carriers for enzymes and microbial cells, as heat carriers for cold storage, and as sustained-release carriers for fragrances.

ハイドロゲルとして用いられている代表的な合成高分子
としては、ポリ−2−ヒドロキシエチルメタクリレ−1
−、ポリアクリル酸塩、ポリビニルピロリドン、ポリエ
チレンオキサイド、あるいは加水分解ポリアクリロニト
リル等が知られているが、最近、特にポリビニルアルコ
ール(以下PVAと略記)のハイドロゲルが注目されて
いる。
A typical synthetic polymer used as a hydrogel is poly-2-hydroxyethyl methacrylate-1.
-, polyacrylate, polyvinylpyrrolidone, polyethylene oxide, hydrolyzed polyacrylonitrile, etc., but recently, hydrogels of polyvinyl alcohol (hereinafter abbreviated as PVA) have particularly been attracting attention.

PVA含水ゲルの力学的強度を向上させるため。To improve the mechanical strength of PVA hydrogel.

ホルムアルデヒドによるホルマール化、グルタルアルデ
ヒドなどの架橋剤を用いて化学的にPVAを架橋させる
方法、ホウ酸、コンゴーレッド、グリセリンなどの増粘
剤を添加してPVA水溶液をゲル化させる方法、または
、γ線、電子線、紫外線などを照射してPVAを架橋す
る方法、さらに。
Formalization with formaldehyde, a method of chemically crosslinking PVA using a crosslinking agent such as glutaraldehyde, a method of gelling a PVA aqueous solution by adding a thickener such as boric acid, Congo red, or glycerin, or γ A method of crosslinking PVA by irradiating it with radiation, electron beam, ultraviolet light, etc.;

チタン、アルミニウム、ジルコニウム、錫、バナジウム
、クロム、銅、コバルトなどの金属化合物を添加して配
位結合化する方法などが知られている。しかしながら、
これらの方法で得られるPVA含水ゲルは分子鎖間に架
橋結合が導入されるため、機械的強度と耐熱水性は向上
するものの粘着性、あるいは低温下(零度以下)での柔
軟性には劣る。
A known method is to add a metal compound such as titanium, aluminum, zirconium, tin, vanadium, chromium, copper, or cobalt to form a coordinate bond. however,
Since the PVA hydrogel obtained by these methods has crosslinks introduced between molecular chains, it has improved mechanical strength and hot water resistance, but is inferior in stickiness or flexibility at low temperatures (below zero degrees).

[発明が解決しようとする問題点] このようにこれまでのPVAハイドロゲルは高含水率で
透明性に優れているものの、粘着性は全くない、そのた
め、これらのPVAハイドロゲルを経皮吸収製剤や診断
用の導電性ゲルとして使用する際には、生体に固定され
る場合に他の粘着テープ等の手段を使用せざるを得ない
、また、従来のPVAハイドロゲルは高含水率を有して
いるものの空気中に放置すると水の飛散が早く、保水性
に劣るものである。さらに、高含水率のため0℃以下の
低温では凍結し、柔軟性が失われてしまうものしか得ら
れなかった。
[Problems to be solved by the invention] As described above, although conventional PVA hydrogels have high water content and excellent transparency, they have no adhesiveness at all. When used as a conductive gel for diagnostic purposes, it is necessary to use other means such as adhesive tape when fixing it to a living body, and conventional PVA hydrogel has a high water content. However, if it is left in the air, water will scatter quickly and its water retention properties will be poor. Furthermore, due to its high water content, it freezes at low temperatures below 0° C., resulting in loss of flexibility.

本発明は、従来のPVAハイドロゲルの欠点。The present invention addresses the shortcomings of conventional PVA hydrogels.

すなわち、生体組織に対する低粘着性と保水性、低温下
での柔軟性、およびイオン導電性等を改良することを目
的とする。
That is, the purpose is to improve low adhesion to living tissues, water retention, flexibility at low temperatures, ionic conductivity, etc.

[目的を達成するための手段] 本発明者らは、PVAハイドロゲルに、粘着性。[Means to achieve the purpose] We found that the PVA hydrogel had a sticky property.

保水性、低温柔軟性、および、イオン導電性を付与する
目的で、鋭意研究を重ねた結果、二価の金属塩水溶液に
PVAを溶解させて冷却ゲル化させると上記の目的を達
成できることを見い出した。
As a result of intensive research aimed at imparting water retention, low-temperature flexibility, and ionic conductivity, it was discovered that the above objectives could be achieved by dissolving PVA in an aqueous divalent metal salt solution and cooling it to gel. Ta.

[作用および実施例] 本発明のPVAゲルは保水性、低温柔軟性、およびイオ
ン導電性に優れるうえに、粘着性にも優れたものである
[Function and Examples] The PVA gel of the present invention has excellent water retention, low-temperature flexibility, and ionic conductivity, as well as excellent adhesiveness.

かかる粘着性PVAハイドロゲルが得られる理由は明白
ではないが、次のように考えられる。
The reason why such a sticky PVA hydrogel is obtained is not clear, but it is thought to be as follows.

二価の金属塩でもチタン、アルミニウム、ジルコニウム
、錫、バナジウム、クロム、銅5あるいはコバルト等の
金属塩を用いた場合、それら金属塩はPVAの水酸基と
の反応性に富むため、低濃度の金属塩でさえも配位結合
により分子鎖間でコンプレックスを形成し不溶化してし
まう、また、−価の金属塩である塩化カリウム、塩化銀
、塩化セシウム、塩化タリウム、塩化ナトリウム、塩化
リチウム等の場合は反応性に乏しく、そのうえこれらの
塩水溶液はPVAの沈殿剤となるため、高濃度溶液から
の均一なゲルは得られにくい。ところが、塩化亜鉛、塩
化カルシウム、塩化ストロンチウム、塩化パラジウム、
塩化バリウム、塩化ビスマス、塩化ベリリウム、塩化マ
グネシウム、塩化マンガン、塩化ニッケル等の二価金属
塩の場合は上記の一価の金属塩と異なり、それらの金属
塩の濃厚溶液でもPVAの沈殿は生じず、また、配位結
合によるコンプレックスが形成されないで。
When divalent metal salts such as titanium, aluminum, zirconium, tin, vanadium, chromium, copper 5, or cobalt are used, these metal salts are highly reactive with the hydroxyl groups of PVA, so low concentrations of metals may be used. Even salts form complexes between molecular chains due to coordination bonds and become insolubilized, and -valent metal salts such as potassium chloride, silver chloride, cesium chloride, thallium chloride, sodium chloride, lithium chloride, etc. have poor reactivity, and in addition, aqueous solutions of these salts act as precipitants for PVA, making it difficult to obtain uniform gels from highly concentrated solutions. However, zinc chloride, calcium chloride, strontium chloride, palladium chloride,
In the case of divalent metal salts such as barium chloride, bismuth chloride, beryllium chloride, magnesium chloride, manganese chloride, and nickel chloride, unlike the monovalent metal salts mentioned above, PVA does not precipitate even in concentrated solutions of these metal salts. , and no complexes are formed due to coordination bonds.

PVA分子鎖間の弱い架橋構造が形成され、ゲル化が起
こり、その結果として保水性、低温柔軟性、イオン導電
性に優れるうえに透明で粘着性も付与されたものと考え
られる。
It is thought that a weak cross-linked structure between PVA molecular chains is formed and gelation occurs, resulting in excellent water retention, low-temperature flexibility, and ionic conductivity, as well as transparency and adhesive properties.

[実施例] 本発明に用いるPVAは、ケン化度80モル%以上、好
ましくは90モル%以上のものがよい。
[Example] The PVA used in the present invention has a degree of saponification of 80 mol% or more, preferably 90 mol% or more.

平均重合度は粘度平均で500以上とくに 1,000
以上が好ましい。
The average degree of polymerization is viscosity average of 500 or more, especially 1,000
The above is preferable.

本発明において用いられる二価の金属塩は、PVAの分
子鎖と配位結合によるコンプレックス形成を生じない金
属塩1例えば塩化亜鉛、塩化カルシウム、塩化ストロン
チウム、塩化パラジウム、塩化バリウム、塩化ビスマス
、塩化ベリリウム、塩化マグネシウム、塩化マンガン、
あるいは塩化ニッケルなどが好ましい。これらの金属塩
の中でもとくに、PVAに対する溶解性や、水との混合
割合と凝固点降下の関係などから、塩化カルシウムが好
ましい。
The divalent metal salt used in the present invention is a metal salt that does not form a complex with the molecular chain of PVA due to coordination bonds. , magnesium chloride, manganese chloride,
Alternatively, nickel chloride is preferable. Among these metal salts, calcium chloride is particularly preferred in view of its solubility in PVA and the relationship between the mixing ratio with water and freezing point depression.

本発明の特徴は、PVAをゲル化させる場合、二価の金
属塩水溶液を用いることであるが、上記の種々の二価金
属塩中で塩化カルシウムが最も好ましい。しかし、これ
ら二価金属塩以外のカルシウム化合物、例えば、酢酸カ
ルシウム、安息香酸カルシウム、臭化カルシウム、炭化
カルシウム。
A feature of the present invention is that a divalent metal salt aqueous solution is used when PVA is gelled, and among the various divalent metal salts mentioned above, calcium chloride is most preferred. However, calcium compounds other than these divalent metal salts, such as calcium acetate, calcium benzoate, calcium bromide, and calcium carbide.

炭酸カルシウム、くえん酸カルシウム、ふっ化カルシウ
ム、水酸化カルシウム、次亜リン酸カルシウム、乳酸カ
ルシウム、硝酸カルシウム、しゅう酸カルシウム、リン
酸二水素カルシウム、リン酸水素カルシウム、リン酸三
カルシウム、サリチル酸カルシウム、けい酸カルシウム
、ステアリン酸カルシウム、硫酸カルシウムなどの単独
あるいは併用使用も可能である。これらの金属塩と水と
の混合割合は、任意に選択できるが、水と金属塩との混
合割合が、得られるP’VAゲルの強度や粘着性を大き
く左右する。従って、目的に応じて混合割合は適宜選定
すべきであるが、通常、水対金属塩の比は98:2〜2
0:80(重量比)、好ましくは90:10〜40 :
 60である。
Calcium carbonate, calcium citrate, calcium fluoride, calcium hydroxide, calcium hypophosphite, calcium lactate, calcium nitrate, calcium oxalate, calcium dihydrogen phosphate, calcium hydrogen phosphate, tricalcium phosphate, calcium salicylate, silicic acid Calcium, calcium stearate, calcium sulfate, etc. can be used alone or in combination. Although the mixing ratio of these metal salts and water can be selected arbitrarily, the mixing ratio of water and metal salts greatly influences the strength and adhesiveness of the obtained P'VA gel. Therefore, the mixing ratio should be selected appropriately depending on the purpose, but usually the ratio of water to metal salt is 98:2 to 2.
0:80 (weight ratio), preferably 90:10-40:
It is 60.

本発明においては、まず金属塩水溶液を目的に応じて所
定の濃度に調製した後、PVA溶液を調製するのである
が、r’VA濃度も目的とする強度や粘着性に応じて2
〜50重量%の範囲に調製するのがよい、このような濃
厚溶液の調製は、一般にPVAを加熱溶解させることに
より行われるが。
In the present invention, a metal salt aqueous solution is first prepared to a predetermined concentration according to the purpose, and then a PVA solution is prepared.
Preparation of such a concentrated solution, preferably in the range of ~50% by weight, is generally carried out by heating and dissolving the PVA.

単に攪拌下での加熱あるいはオートクレーブや電子レン
ジを用いてもよい。
Simply heating while stirring or using an autoclave or microwave oven may be used.

完全に溶解させたPVA溶液を任意の形状の容器や鋳型
あるいはガラス板やプラスチックフィルム上に流延させ
た後、常温以下の低温にて放置することによりゲル化さ
せると本発明のゲルが得られる。その場合、温度が低い
ほど同じPVA濃度でも強度が高いゲルが?j)られる
ので、−20℃前後のフリーザー中にてゲル化させるの
が好ましい。
The gel of the present invention can be obtained by casting a completely dissolved PVA solution onto a container, mold, glass plate, or plastic film of any shape, and then allowing it to gel by leaving it at a low temperature below room temperature. . In that case, the lower the temperature, the stronger the gel at the same PVA concentration? j) It is preferable to gel it in a freezer at around -20°C.

このようにして得られるゲルの強度、耐熱性等をさらに
高める必要のある場合は、ゲル形成後に本発明で用いる
二価の金属塩以外の二価の金属塩。
If it is necessary to further enhance the strength, heat resistance, etc. of the gel thus obtained, use a divalent metal salt other than the divalent metal salt used in the present invention after gel formation.

例えば、塩化鋼、塩化チタン等の使用も可能であり、ま
た、ホウ砂やホウ酸の使用、あるいは放射線や電子線の
照射も可能である。
For example, it is possible to use chlorinated steel, titanium chloride, etc., and it is also possible to use borax or boric acid, or to irradiate with radiation or electron beams.

本発明の粘着性PVAゲルは、使用目的に応じて要求さ
れる種々の形状に成形することができる。
The adhesive PVA gel of the present invention can be molded into various shapes required depending on the intended use.

例えば、フィルム、シート、ロンド、ブロック、テープ
、チューブ、繊維状のものから複雑な形状のものまで自
由自在に成形加工が可能である。また、繊維、不織布1
発泡シート、編物、あるいは織物との複合体などにも加
工できる。
For example, it is possible to freely mold anything from films, sheets, ronds, blocks, tapes, tubes, fibers, to complex shapes. In addition, fibers, nonwoven fabrics 1
It can also be processed into foam sheets, knitted fabrics, or composites with textiles.

本発明のPVAゲルは保水性に優れるが、さらに保水性
を高めるためグリセリンやエチレングリコール等の多価
アルコールの添加、あるいは、他の水溶性高分子1例え
ば、ゼラチン、シクロデキストリン、カルボキシメチル
セルロース、デンプン、カーボボール、カラヤゴ11、
デンプン−アクリル酸ソーダ共重合体、ビニルアルコー
ル−アクリル酸ソーダ共重合体、ポリアクリル酸ソーダ
等の併用も可能である。また、本発明のPVAゲルはイ
オン導電性に優れるが、さらにイオン導電性を向上させ
るために塩化リチウム、過塩素酸リチウム、塩化第1鉄
、硫酸アンモニウム、硝酸カリウム、硝酸ナトリウム、
炭酸ナトリウム、チオシアン酸ナトリウム、トリフルオ
ロメタンスルホン酸リチウム等の無機塩類の添加も“可
能である。
The PVA gel of the present invention has excellent water retention, but in order to further increase the water retention, polyhydric alcohols such as glycerin and ethylene glycol may be added, or other water-soluble polymers such as gelatin, cyclodextrin, carboxymethyl cellulose, and starch may be added. , Carbo Ball, Karayago 11,
It is also possible to use starch-sodium acrylate copolymer, vinyl alcohol-sodium acrylate copolymer, polysodium acrylate, and the like. The PVA gel of the present invention has excellent ionic conductivity, but in order to further improve the ionic conductivity, lithium chloride, lithium perchlorate, ferrous chloride, ammonium sulfate, potassium nitrate, sodium nitrate,
It is also possible to add inorganic salts such as sodium carbonate, sodium thiocyanate, and lithium trifluoromethanesulfonate.

また1本発明の粘着性PVAゲルを経皮吸収製剤として
適用させる場合には、経皮適用可能な生理活性物質を添
加することができる。その生理活性物質は、例えば、パ
ップ剤用の薬物として、メントール、ハツカ、サリチル
酸エステル、カンファー、カブサイシン、トウガラシエ
キスなど、局所麻酔剤としてキシロカイン、ペンシカイ
ン、プロ力インなど、狭心症薬としてニトログリセリン
、硝酸イソソルビドなど、ステロイドとしてプレゾニゾ
ロン、デキサメタシン、ヒドロコルチゾン、酢酸デキサ
メタシン、酢酸ヒドロコルチゾンなど、β−遮断薬とし
てプロプラノロール、アルプレノロール、ピンドロール
など、血圧降下剤として塩酸クロニジン、塩酸ブニトロ
ロール、ニフェジピン、カプトプリルなど、気管支拡張
薬としてメチルエフェドリン、クロルブレナリン、サル
ブタモール、テルブタリンなど、喘息薬としてクロモグ
リク酸など、アレルギー性鼻炎薬としてフマル酸ケトチ
フェンなど、解熱消炎tll jrM剤としては、ジク
ロフェナックナトリウム、インドメタシンナトリウムな
ど、ホルモン剤としては、プロスタグランジン、ニス1
〜ラジオールなど、抗生物質としては、グロルテトラサ
イクリン、オキシテトラサイクリン、ドキシサイクリン
、ペニシリン類、セファロスポリン類、スルホンアミド
類、エリスロマイシン、トフラマイシン、塩酸ジベカシ
ンなどが挙げられる。さらにペプチド系薬物として、イ
ンシュリン、ソマトスタチン、黄体形成ホルモン放出ホ
ルモン(Ll−IRH)、プロラクチン、カルヒトニン
、成長ホルモンなどもnf能であるが、これらの高分子
量薬物の場合は、皮膚透過性が劣るため定電流イオント
フォレシスにより効率よく皮膚透過性を高めることがで
きる。これら生理活性物質は単独でも併用でも可能であ
る。
Furthermore, when the adhesive PVA gel of the present invention is applied as a transdermal absorption preparation, a physiologically active substance that can be applied transdermally can be added. The physiologically active substances include, for example, menthol, peppermint, salicylic acid ester, camphor, kabsaicin, and chili pepper extract as drugs for poultices, xylocaine, pensicaine, and procyone as local anesthetics, and nitroglycerin as an angina drug. , isosorbide nitrate, etc., steroids such as prezonisolone, dexamethacin, hydrocortisone, dexamethacin acetate, hydrocortisone acetate, etc., β-blockers such as propranolol, alprenolol, pindolol, antihypertensive agents such as clonidine hydrochloride, bunitrol hydrochloride, nifedipine, captopril, etc., bronchial Extensive drugs such as methylephedrine, chlorbrenaline, salbutamol, and terbutaline; asthma drugs such as cromoglycic acid; allergic rhinitis drugs such as ketotifen fumarate; antipyretic and anti-inflammatory agents such as diclofenac sodium and indomethacin sodium; and hormone drugs such as: prostaglandin, varnish 1
-Radiol, etc. Antibiotics include glortetracycline, oxytetracycline, doxycycline, penicillins, cephalosporins, sulfonamides, erythromycin, toframycin, dibekacin hydrochloride, and the like. Furthermore, peptide drugs such as insulin, somatostatin, luteinizing hormone-releasing hormone (Ll-IRH), prolactin, calhitonin, and growth hormone have NF activity, but these high molecular weight drugs have poor skin permeability. Constant current iontophoresis can efficiently increase skin permeability. These physiologically active substances can be used alone or in combination.

上記、生理活性物質含有の粘着性PvΔハイドロゲルを
:A製するには、例えば次のようにして装造される。塩
化カルシウム25〜35重量%水溶液中にPvΔ粉末を
濃度10〜16重斌%になるように入れオートクレーブ
にて完全に溶解させ、50〜60℃に冷えてから、上記
の生理活性物質を1〜30重址%添加し攪拌溶解させた
後、適当な材料の上に流延し一20℃のフリーザー中で
一昼夜放置してゲル化させることにより得られる。
In order to produce the above-mentioned adhesive PvΔ hydrogel containing a physiologically active substance:A, it is assembled, for example, as follows. Add PvΔ powder to a concentration of 10 to 16% by weight in an aqueous solution of 25 to 35% by weight of calcium chloride, completely dissolve in an autoclave, cool to 50 to 60°C, and then add 1 to 10% of the above physiologically active substances. After adding 30% by weight and dissolving with stirring, the mixture is cast onto a suitable material and left overnight in a freezer at -20°C to gel.

この場合、生理活性物質の皮膚透過性を高める必要のあ
る際には、多価アルコール等の添加も可能である。
In this case, if it is necessary to increase the skin permeability of the physiologically active substance, it is also possible to add polyhydric alcohol or the like.

実施例1゜ 市販PVA (ケン化度99.5モル%、平均重合度1
,700)に第1表に示す金属塩と、その金属塩の水溶
液濃度の溶媒を同表に示すPVA濃度になるように加え
、オートクレーブ中で110℃にて−30分間加熱しP
VA溶液を調製した。ついで得られた溶液をポリエチレ
ンフィルム上に流延し。
Example 1 Commercially available PVA (saponification degree 99.5 mol%, average polymerization degree 1
, 700) were added with the metal salt shown in Table 1 and a solvent with an aqueous solution concentration of the metal salt so as to have the PVA concentration shown in the same table, and heated in an autoclave at 110°C for -30 minutes.
A VA solution was prepared. The resulting solution was then cast onto a polyethylene film.

このものを−20℃のフリーザー中にて一昼夜ゲル化さ
せ、厚さ約1 mmのシート状のPVAゲルを得た。 
  ・ 得られた各PVAゲルにつき、ボランティア5名の眉に
粘着テープの固定なしにPVAゲル試料(5X5cm)
を貼付し、24時間後のI’VAゲル試料と皮膚との粘
着面積車を検討した。その結果を同じく第1表に示す。
This product was gelled overnight in a -20°C freezer to obtain a sheet-like PVA gel with a thickness of about 1 mm.
- For each PVA gel obtained, PVA gel samples (5X5 cm) were placed on the eyebrows of 5 volunteers without fixation of adhesive tape.
24 hours later, the adhesion area between the I'VA gel sample and the skin was examined. The results are also shown in Table 1.

[以下余白] 第1表 比較例1゜ 市販PVA (ケン化度99.5モル%、平均重合度 
1.700)に第2表に示す金属塩と、その金属塩の水
溶液濃度の溶媒を同表に示すP V A 1度になるよ
うに加え、オートクレーブ中にて加熱溶解を試みたが、
比較実験番号1〜3の場合、PVAは殆ど溶解しなかっ
た。また、比較実験番号4〜6の場合も一部は溶解する
が不均一なゲルが生成した。そこで、金属塩の水溶液濃
度を2〜10%と低下させ溶液を作製し、実施例】と同
様ゲルを作製したところ、乳白色のゲルが得られたが、
それらは全く粘着性を示さなかった。
[Margin below] Table 1 Comparative Example 1゜Commercially available PVA (saponification degree 99.5 mol%, average polymerization degree
1.700) were added with the metal salt shown in Table 2 and a solvent with an aqueous solution concentration of the metal salt at a P V A of 1 degree shown in the same table, and an attempt was made to dissolve it by heating in an autoclave.
In the case of comparative experiment numbers 1 to 3, PVA was hardly dissolved. Moreover, in the case of Comparative Experiment Nos. 4 to 6, although some of the gels were dissolved, non-uniform gels were formed. Therefore, when a solution was prepared by lowering the concentration of the metal salt aqueous solution to 2 to 10% and a gel was prepared in the same manner as in Example, a milky white gel was obtained.
They showed no stickiness at all.

第2表 実施例2゜ 市販PVA (ケン化度95モル%、平均重合度2.2
00) 75 gをあらかじめ別に調製した塩化カルシ
ウムニ水塩30重景%水溶液425g中に添加し、オー
トクレーブ中で110℃にて30分間加熱溶解させた後
、ポリエチレン袋に封入し一20℃のフリーザー中で一
昼夜放置することにより保冷袋を作製した。このゲルは
一20℃でも凍結することなく柔軟性を呈し、頭部、あ
るいは皮膚に触れても堅さにもとづく不快感はなかった
。また。
Table 2 Example 2 Commercially available PVA (degree of saponification 95 mol%, average degree of polymerization 2.2
00) 75 g was added to 425 g of a 30% aqueous solution of calcium chloride dihydrate prepared separately in advance, heated and dissolved in an autoclave at 110°C for 30 minutes, then sealed in a polyethylene bag and placed in a freezer at -20°C. A cold bag was prepared by leaving it in the bag overnight. This gel exhibited flexibility without freezing even at -20°C, and did not cause any discomfort due to its hardness when it touched the head or skin. Also.

−20℃−晩放置、室温−晩放置のサイクルを30回試
みたが、ゲルの強度は若干高くなったものの、ゲル中の
水の離しよう現象は全く生じなかった。
A cycle of leaving at -20° C. overnight and leaving at room temperature overnight was tried 30 times, but although the strength of the gel increased slightly, no phenomenon of water separation in the gel occurred.

実施例3゜ 実施例1中の実施実験番号3により得られたI〕VAゲ
ルを約5X5mm程度に切断した後、真空乾燥器により
約3日間脱水し、白色の塩化カルシウム含有PVA乾燥
ゲルを得た。この乾燥ゲル約50gを内容置駒10 L
のガラス製デシケータの底に入れ湿度変化を測定したと
ころ、最初約80%の湿度が数時間で0%に達し、3ケ
月以上その湿度を保った。
Example 3 VA gel obtained in Experiment No. 3 in Example 1 was cut into approximately 5 x 5 mm pieces and dehydrated for approximately 3 days in a vacuum dryer to obtain a white dried PVA gel containing calcium chloride. Ta. Place approximately 50g of this dry gel into a 10L piece.
When the humidity was measured by placing it in the bottom of a glass desiccator, the humidity was about 80% at first, but it reached 0% in a few hours and remained at that humidity for more than three months.

実施例4゜ 実施例1中の実施実験番号5により得られたP■Δゲル
をJ I S  K−6911,5−13項に準する方
法で体積抵抗率を測定したところ、4X10’ Ωcm
の値を示した。また、このゲルに電極コネクターを付け
、心電図を測定したところ良好な結果が得られた。
Example 4 The volume resistivity of the P■Δ gel obtained in Experiment No. 5 in Example 1 was measured in accordance with JIS K-6911, Section 5-13, and it was found to be 4X10' Ωcm.
The value of Also, when an electrode connector was attached to this gel and an electrocardiogram was measured, good results were obtained.

実施例5゜ 市販PVA (ケン化度99.5モル%、平均重合度 
1,700)  13 gをあらかじめ別に調製した塩
化カルシウムニ水塩30重景%水溶液87.中に添加し
、オートクレーブ中で110℃にて30分間加熱溶解さ
せた。その濃厚溶液を50〜60℃に冷却させてからサ
ルチル酸グリコールIg、L−メントール1.、、DL
−カンフル0.5g、酢酸トコフェロール0.3gを添
加し攪拌溶解させポリエステルフィルムJ−に流延し、
その上に不織布をのせた後、−20℃のフリーザー中に
て一昼夜放置することにより消炎・鎮痛パップ剤を作製
した。このハップ剤(10X L Ocm)を人の背中
に貼付したところ、他の粘着テープの補助なしで皮膚に
対する粘着性が優れ、24時間後でも初期の粘着力を保
持しており、また、皮膚への刺激が少なく皮膚のカブレ
もほとんど認められなかった。
Example 5 Commercially available PVA (saponification degree 99.5 mol%, average polymerization degree
1,700) 13 g of calcium chloride dihydrate 30% aqueous solution 87. and heated and dissolved in an autoclave at 110°C for 30 minutes. The concentrated solution was cooled to 50-60°C, and then added 1 g of glycol salicylate and 1. ,,DL
- Add 0.5 g of camphor and 0.3 g of tocopherol acetate, stir and dissolve and cast onto polyester film J-,
After placing a nonwoven fabric thereon, an anti-inflammatory/analgesic poultice was prepared by leaving it in a -20°C freezer overnight. When this poultice (10X L Ocm) was applied to the back of a person, it had excellent adhesion to the skin without the aid of other adhesive tapes, and even after 24 hours, it maintained its initial adhesive strength, and it showed no resistance to the skin. There was little irritation and almost no skin irritation was observed.

実施例6゜ 市販r’VA (ケン化度99.5モル%、平均重合度
 1,700) 2.6gをあらかじめ別に調製した塩
化カルシウムニ水塩30重量%水溶液17.4g中に添
加し、オートクレーブ中で110℃にて30分間加熱溶
解させた。その溶液を50〜60℃に冷却させてからジ
クロフェナックナトリウム0.5gとニコチン酸オクチ
ル1.5gを添加し攪拌下で溶解させガラス製のシャー
レに入れた後、−20℃のフリーザー中にて一昼夜放置
することにより経皮吸収製剤を作製した、この製剤のカ
ラゲニン足浮腫に対する制御作用を Wis tar系
雄ラソう、(体重約2sOg)にて検討したところ、8
時間後ではガラゲニン足浮腫制御効果が顕著に認められ
た。
Example 6 2.6 g of commercially available r'VA (degree of saponification 99.5 mol%, average degree of polymerization 1,700) was added to 17.4 g of a 30% by weight aqueous solution of calcium chloride dihydrate prepared separately in advance, The mixture was heated and dissolved in an autoclave at 110°C for 30 minutes. The solution was cooled to 50-60°C, then 0.5 g of diclofenac sodium and 1.5 g of octyl nicotinate were added, dissolved under stirring, and placed in a glass petri dish, then kept in a -20°C freezer overnight. A transdermal absorption preparation was prepared by leaving it to stand, and the control effect of this preparation on carrageenan paw edema was investigated in male Wi star cattle (body weight approximately 2 sOg).8
After several hours, the effect of galagenin on controlling paw edema was clearly observed.

実施例7゜ 市販PVA (ケン化度99.5モル%、平均重合度 
1,700) 2.6gをあらかじめ別に調製した塩化
カルシウム−水塩30重に%水溶液]、7.4゜中に添
加し、オートクレーブ中で110”Cにて30分間加熱
溶解させた。その溶液を50〜60℃に冷却させてから
塩酸グロニジン0.2gを添加し攪拌下で溶解させポリ
エステルフィルム(厚み20μm)上に流延した後、−
20℃のフリーザー中にて一昼夜放置することにより経
皮吸収製剤を作製した。この製剤の血圧降下作用を W
istar系雄ラット(体重約250g)にて検討した
ところ、48時間にわたって血圧降下が認められた。
Example 7 Commercially available PVA (saponification degree 99.5 mol%, average polymerization degree
1,700) 2.6g was added to a separately prepared 30% aqueous solution of calcium chloride hydrate], 7.4°, and dissolved by heating at 110"C for 30 minutes in an autoclave.The solution was cooled to 50 to 60°C, 0.2 g of glonidine hydrochloride was added, dissolved under stirring, and cast onto a polyester film (thickness: 20 μm).
A transdermal absorption preparation was prepared by leaving it in a freezer at 20°C overnight. W
When examined in male istar rats (body weight approximately 250 g), a decrease in blood pressure was observed over 48 hours.

実施例8゜ 市販PVA (ケン化度99.5モル%、平均重合度1
.200) 20 gをあらかじめ別に調製した塩化カ
ルシウムニ水塩30重量%水溶液80g中に添加し、オ
ートクレーブ中で1.10’Cにて30分間加熱溶解さ
せた。その溶液を50〜60℃に冷却させてから市販の
ジャスミン香料Logを添加し攪拌下で均一に分散させ
プラスチック容器に入れた後、−20℃のフリーザー中
にて一昼夜放置することによりゲル消臭芳香剤を作製し
た。このものを乗用車内の後部に設置し芳香持続性を検
討したところ、約3ケ月間屯内の芳香効果が認められた
Example 8 Commercially available PVA (saponification degree 99.5 mol%, average polymerization degree 1
.. 200) was added to 80 g of a 30% by weight aqueous solution of calcium chloride dihydrate prepared separately in advance, and the mixture was heated and dissolved in an autoclave at 1.10'C for 30 minutes. After cooling the solution to 50 to 60°C, add commercially available jasmine fragrance Log, disperse it uniformly under stirring, and put it in a plastic container, and then leave it in a -20°C freezer overnight to deodorize the gel. A fragrance was created. When this product was installed in the rear of a passenger car and the persistence of the fragrance was examined, it was found that the fragrance remained effective for about 3 months.

[発明の効果コ 本発明の粘着性PVAハイドロゲル組成物は。[Effects of invention The adhesive PVA hydrogel composition of the present invention.

p v Aのゲル化に際して毒性の強い化学的架橋剤や
触媒などは一切使用していないので、生体組織に対する
刺激性が殆どなく、生理活性物質の活性の低下や変質も
おこらない。また、機械的強度、粘着性、透明性、低温
下での柔軟性、保水性、およびイオン導電性に優九でい
るため5保冷剤、経皮吸収製剤、生体電極用ゲルとして
応用できる。
Since no highly toxic chemical cross-linking agents or catalysts are used during the gelation of pvA, there is almost no irritation to living tissues, and there is no reduction in the activity or alteration of physiologically active substances. In addition, it has excellent mechanical strength, adhesiveness, transparency, flexibility at low temperatures, water retention, and ionic conductivity, so it can be applied as ice packs, transdermal absorption preparations, and gels for bioelectrodes.

また、酵素や菌体の固定化担体、さらに、昆虫忌避剤、
殺虫剤、殺菌剤、フェロモン、農薬、芳香剤の徐放性担
体、消臭剤、病人用マット、あるいは乾燥剤等として幅
広く応用することができる。
In addition, we also use immobilized carriers for enzymes and bacterial cells, as well as insect repellents,
It can be widely applied as a sustained release carrier for insecticides, fungicides, pheromones, agricultural chemicals, and fragrances, deodorants, mats for sick people, desiccants, etc.

特許出願人 株式会社バイオマテリアル・ユニバースPatent applicant: Biomaterial Universe Co., Ltd.

Claims (1)

【特許請求の範囲】 1)水以外にポリビニルアルコールと二価の金属塩を主
成分とすることを特徴とする粘着性PVAハイドロゲル
組成物。 2)ポリビニルアルコールの粘度平均重合度が500以
上である特許請求の範囲第1項記載の粘着性PVAハイ
ドロゲル組成物。 3)ポリビニルアルコールのケン化度が80モル%以上
である特許請求の範囲第1項記載の粘着性PVAハイド
ロゲル組成物。 4)ハイドロゲル中におけるポリビニルアルコールの含
有量が5〜80重量%である特許請求の範囲第1項記載
の粘着性PVAハイドロゲル組成物。 5)二価の金属塩が塩化亜鉛、塩化カルシウム、塩化ス
トロンチウム、塩化パラジウム、塩化バリウム、塩化ビ
スマス、塩化ベリリウム、塩化マグネシウム、塩化マン
ガン、塩化ニッケルである特許請求の範囲第1項記載の
粘着性PVAハイドロゲル組成物。 6)ハイドロゲル中における金属塩化物の含有量が2〜
90重量%である特許請求の範囲第1項記載の粘着性P
VAハイドロゲル組成物。
[Scope of Claims] 1) An adhesive PVA hydrogel composition characterized by containing polyvinyl alcohol and a divalent metal salt as main components in addition to water. 2) The adhesive PVA hydrogel composition according to claim 1, wherein the viscosity average degree of polymerization of polyvinyl alcohol is 500 or more. 3) The adhesive PVA hydrogel composition according to claim 1, wherein the degree of saponification of polyvinyl alcohol is 80 mol% or more. 4) The adhesive PVA hydrogel composition according to claim 1, wherein the content of polyvinyl alcohol in the hydrogel is 5 to 80% by weight. 5) The adhesive according to claim 1, wherein the divalent metal salt is zinc chloride, calcium chloride, strontium chloride, palladium chloride, barium chloride, bismuth chloride, beryllium chloride, magnesium chloride, manganese chloride, or nickel chloride. PVA hydrogel composition. 6) The content of metal chloride in the hydrogel is 2~
The adhesive P according to claim 1, which is 90% by weight.
VA hydrogel composition.
JP63057960A 1988-03-11 1988-03-11 Adhesive PVA hydrogel composition Expired - Lifetime JP2824460B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63057960A JP2824460B2 (en) 1988-03-11 1988-03-11 Adhesive PVA hydrogel composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63057960A JP2824460B2 (en) 1988-03-11 1988-03-11 Adhesive PVA hydrogel composition

Publications (2)

Publication Number Publication Date
JPH01230659A true JPH01230659A (en) 1989-09-14
JP2824460B2 JP2824460B2 (en) 1998-11-11

Family

ID=13070582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63057960A Expired - Lifetime JP2824460B2 (en) 1988-03-11 1988-03-11 Adhesive PVA hydrogel composition

Country Status (1)

Country Link
JP (1) JP2824460B2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09267453A (en) * 1996-03-29 1997-10-14 Japan Atom Energy Res Inst PVA hydrogel laminate and method for producing the same
EP1133918A1 (en) * 2000-03-14 2001-09-19 Sumitomo Chemical Co.,Ltd. Method for denaturing allergens using calcium or strontium salts
WO2001068746A1 (en) * 2000-03-15 2001-09-20 Ueda Textile Science Foundation Molding made of polyvinyl alcohol and process for producing the same
FR2807656A1 (en) * 2000-04-18 2001-10-19 Oreal ANTITRANSPIRANT COSMETIC COMPOSITION THAT DOES NOT STAIN CLOTHING
FR2807655A1 (en) * 2000-04-18 2001-10-19 Oreal Composition useful for the prevention and treatment of cutaneous wrinkles comprises extracts of leucocyanadines, triterpenes and fish cartilage
JP2006083081A (en) * 2004-09-15 2006-03-30 Taisho Pharmaceut Co Ltd Mucosal fluid
JP2007031601A (en) * 2005-07-28 2007-02-08 Nippon Synthetic Chem Ind Co Ltd:The Hydrogel
JP2008538558A (en) * 2005-04-22 2008-10-30 アール アンド エイチ ミネラルズ ビー.ブイ. Inorganic salt gel composition
JP2010053290A (en) * 2008-08-29 2010-03-11 Kuraray Co Ltd Method for manufacturing polyvinyl alcohol film
CN114195117A (en) * 2021-11-23 2022-03-18 广东省科学院化工研究所 Carbon aerogel, sensor, and preparation method and application of sensor
CN114349981A (en) * 2021-12-15 2022-04-15 江苏大学 A kind of preparation method of PVA double-crosslinked hydrogel based on 2D resin
CN115040689A (en) * 2022-05-11 2022-09-13 上海摩漾生物科技有限公司 High-fluidity hydroxyapatite nano material and preparation method thereof
CN115232335A (en) * 2022-08-30 2022-10-25 孙培豪 Novel polymer gel material for soft rubber toy and preparation process thereof
CN117122717A (en) * 2022-05-18 2023-11-28 大连达伦特香氛科技有限公司 A high-fragrance gel fragrance and its preparation method and use
CN118866561A (en) * 2024-07-09 2024-10-29 武汉工程大学 A phosphorus-activated chitosan-derived carbon composite gel and its preparation method and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928639A (en) * 1972-07-11 1974-03-14
JPS501130A (en) * 1973-05-07 1975-01-08
JPS5457558A (en) * 1977-10-17 1979-05-09 Kuraray Co Ltd Manufacture of molded polyvinyl alcohol-type hydrous gel article

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928639A (en) * 1972-07-11 1974-03-14
JPS501130A (en) * 1973-05-07 1975-01-08
JPS5457558A (en) * 1977-10-17 1979-05-09 Kuraray Co Ltd Manufacture of molded polyvinyl alcohol-type hydrous gel article

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09267453A (en) * 1996-03-29 1997-10-14 Japan Atom Energy Res Inst PVA hydrogel laminate and method for producing the same
EP1133918A1 (en) * 2000-03-14 2001-09-19 Sumitomo Chemical Co.,Ltd. Method for denaturing allergens using calcium or strontium salts
US6830764B2 (en) 2000-03-14 2004-12-14 Shinto Fine Co., Ltd. Method for denaturing allergens
WO2001068746A1 (en) * 2000-03-15 2001-09-20 Ueda Textile Science Foundation Molding made of polyvinyl alcohol and process for producing the same
FR2807656A1 (en) * 2000-04-18 2001-10-19 Oreal ANTITRANSPIRANT COSMETIC COMPOSITION THAT DOES NOT STAIN CLOTHING
FR2807655A1 (en) * 2000-04-18 2001-10-19 Oreal Composition useful for the prevention and treatment of cutaneous wrinkles comprises extracts of leucocyanadines, triterpenes and fish cartilage
WO2001078658A3 (en) * 2000-04-18 2002-04-04 Oreal Divalent manganese salts for reducing odour resulting from bacterial decomposition of human perspiration
WO2001078673A3 (en) * 2000-04-18 2002-05-23 Oreal Non-staining antiperspirant cosmetic composition
JP2006083081A (en) * 2004-09-15 2006-03-30 Taisho Pharmaceut Co Ltd Mucosal fluid
JP2008538558A (en) * 2005-04-22 2008-10-30 アール アンド エイチ ミネラルズ ビー.ブイ. Inorganic salt gel composition
JP2007031601A (en) * 2005-07-28 2007-02-08 Nippon Synthetic Chem Ind Co Ltd:The Hydrogel
JP2010053290A (en) * 2008-08-29 2010-03-11 Kuraray Co Ltd Method for manufacturing polyvinyl alcohol film
CN114195117A (en) * 2021-11-23 2022-03-18 广东省科学院化工研究所 Carbon aerogel, sensor, and preparation method and application of sensor
CN114349981A (en) * 2021-12-15 2022-04-15 江苏大学 A kind of preparation method of PVA double-crosslinked hydrogel based on 2D resin
CN115040689A (en) * 2022-05-11 2022-09-13 上海摩漾生物科技有限公司 High-fluidity hydroxyapatite nano material and preparation method thereof
CN117122717A (en) * 2022-05-18 2023-11-28 大连达伦特香氛科技有限公司 A high-fragrance gel fragrance and its preparation method and use
CN115232335A (en) * 2022-08-30 2022-10-25 孙培豪 Novel polymer gel material for soft rubber toy and preparation process thereof
CN118866561A (en) * 2024-07-09 2024-10-29 武汉工程大学 A phosphorus-activated chitosan-derived carbon composite gel and its preparation method and application

Also Published As

Publication number Publication date
JP2824460B2 (en) 1998-11-11

Similar Documents

Publication Publication Date Title
AU675270B2 (en) Skin adhesive hydrogel, its preparation and uses
JP2824460B2 (en) Adhesive PVA hydrogel composition
JP5232347B2 (en) Blood active compositions and methods for their manufacture and use
JPH05230313A (en) Hydrated gel and its production
US5519020A (en) Polymeric wound healing accelerators
US7972137B2 (en) Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
KR20010112452A (en) Transdermal therapeutic system with neutralized acrylic adhesive patch
JPH06225932A (en) Composition that is possible to extrude for local or percutanous medicine distribution
US5252588A (en) Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
JP2002536118A (en) Gel formed by the interaction of poly (aldehyde) with various substances
RU2249467C2 (en) Medicinal material and products based upon this material
JPH02503637A (en) wound dressing
CN1204020C (en) Terminally sterilized topical patch formulation and method for its production
CN110251457A (en) A kind of anti-tumor sustained-release implant with strong adhesion and hemostatic function and preparation method thereof
US5484604A (en) Cross-linked alginate transdermal medicine delivery devices
US4781926A (en) Transdermal therapeutic composition
CN116509823A (en) Ketorolac tromethamine gel plaster composition, gel plaster and preparation method thereof
HU205013B (en) Process for producing surface therapy plaster containing 5-fluor-uracil
JPS6236314A (en) Locally administrable medicinal composition
CN106937941A (en) A kind of medical skin diminishing inflammation of wound gel and preparation method thereof
JPH07106978B2 (en) Complex patch preparation
CN1056055A (en) Eperisone and mydocalm preparation that percutaneous absorbs
JP2004161684A (en) Film preparation for wound healing containing physiologically active substance
JPH10316590A (en) Topical narcotic for external use
EP0137743A2 (en) Topically administrable pharmaceutical compositions